What are the risks of high estimated average glucose?

High estimated average glucose (eAG) above 126 mg/dL indicates poor blood sugar control and increases risks for diabetes complications like nerve damage, kidney disease, and heart problems. Regular monitoring through HbA1c testing helps identify issues early for better management.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Estimated Average Glucose (eAG)

Estimated average glucose (eAG) is a way to translate your HbA1c test results into the same units (mg/dL or mmol/L) used for daily blood glucose monitoring. While HbA1c shows your average blood sugar control over the past 2-3 months as a percentage, eAG converts this into a number that's easier to understand and compare with your daily glucose readings.

The formula for converting HbA1c to eAG is: eAG (mg/dL) = 28.7 × HbA1c - 46.7. For example, an HbA1c of 7% translates to an eAG of approximately 154 mg/dL, while an HbA1c of 5.7% equals an eAG of about 117 mg/dL.

Normal vs. High eAG Levels

According to the American Diabetes Association, normal eAG levels correspond to an HbA1c below 5.7%, which translates to an eAG below 117 mg/dL. Prediabetes is indicated by an eAG between 117-137 mg/dL (HbA1c 5.7-6.4%), while diabetes is diagnosed when eAG exceeds 137 mg/dL (HbA1c 6.5% or higher).

Stages of Diabetic Kidney Disease by eAG Levels

eAG Range (mg/dL)Kidney FunctionSymptomsReversibility
Below 117<117 mg/dLNormal kidney functionNoneN/A - Maintain levels
117-154117-154 mg/dLHyperfiltration stageUsually noneFully reversible with glucose control
155-183155-183 mg/dLEarly kidney damage (microalbuminuria)None to mildPartially reversible with tight control
Above 183>183 mg/dLProgressive kidney diseaseSwelling, fatigue, nauseaDamage can be slowed but not reversed

Early detection through regular testing is crucial as kidney damage often has no symptoms until advanced stages.

However, optimal metabolic health may require even tighter control. Many functional medicine practitioners recommend maintaining an eAG below 100 mg/dL (HbA1c below 5.0%) for optimal health and longevity. Understanding your eAG levels through regular testing can help you track your metabolic health and make informed decisions about your lifestyle.

Immediate Health Risks of High eAG

When your estimated average glucose remains elevated, your body experiences both immediate and long-term consequences. In the short term, high eAG can lead to symptoms that significantly impact your daily life and well-being.

Energy and Cognitive Effects

High average glucose levels can cause persistent fatigue and brain fog. When your cells can't efficiently use glucose due to insulin resistance or insufficient insulin production, you may experience constant tiredness despite adequate rest. Cognitive function also suffers, with many people reporting difficulty concentrating, memory problems, and reduced mental clarity.

Research published in Diabetes Care found that individuals with elevated HbA1c levels performed worse on cognitive tests compared to those with normal levels, even in the absence of diagnosed diabetes. This cognitive impairment can affect work performance, decision-making, and overall quality of life.

Increased Infection Risk

High blood sugar impairs your immune system's ability to fight off infections. White blood cells don't function properly in a high-glucose environment, making you more susceptible to bacterial and fungal infections. Common infections include urinary tract infections, skin infections, and yeast infections. Wounds also heal more slowly when average glucose is elevated, increasing the risk of complications from minor injuries.

Long-Term Cardiovascular Risks

Perhaps the most serious long-term risk of high eAG is cardiovascular disease. Elevated average glucose levels damage blood vessels through multiple mechanisms, significantly increasing your risk of heart attack, stroke, and other cardiovascular events.

Blood Vessel Damage

Chronic hyperglycemia causes glycation of proteins in blood vessel walls, making them stiff and prone to damage. This process, called advanced glycation end products (AGEs) formation, accelerates atherosclerosis - the buildup of plaque in arteries. A study in the Journal of the American College of Cardiology found that for every 1% increase in HbA1c above normal, cardiovascular disease risk increased by 18%.

High eAG also promotes inflammation and oxidative stress, further damaging the endothelium (inner lining of blood vessels). This damage makes it easier for cholesterol to accumulate in artery walls, forming dangerous plaques that can rupture and cause heart attacks or strokes. Regular monitoring of both glucose and cardiovascular biomarkers can help identify these risks early.

Diabetic Complications from Chronic High eAG

When estimated average glucose remains elevated for years, it can lead to serious diabetic complications, even in people who haven't been formally diagnosed with diabetes. These complications affect multiple organ systems and can significantly impact quality of life.

Neuropathy (Nerve Damage)

High blood sugar damages nerves throughout the body, with peripheral neuropathy being the most common form. This typically starts in the feet and hands, causing numbness, tingling, burning pain, or loss of sensation. According to the National Institute of Diabetes and Digestive and Kidney Diseases, up to 50% of people with diabetes develop some form of neuropathy.

Autonomic neuropathy affects nerves controlling internal organs, potentially causing digestive problems, bladder issues, sexual dysfunction, and abnormal heart rate. Early detection through regular screening and tight glucose control can prevent or slow progression of nerve damage.

Nephropathy (Kidney Disease)

The kidneys' delicate filtering units (nephrons) are particularly vulnerable to high glucose levels. Over time, elevated eAG causes the kidneys to work harder, leading to hyperfiltration and eventual damage to the glomeruli (tiny blood vessels in the kidneys). This can progress to chronic kidney disease and potentially kidney failure requiring dialysis or transplantation.

Early kidney damage often has no symptoms, making regular testing crucial. Microalbuminuria (small amounts of protein in urine) is an early sign of kidney damage that can be detected years before significant kidney function loss occurs.

Retinopathy (Eye Damage)

High average glucose damages the tiny blood vessels in the retina, potentially leading to vision loss. Diabetic retinopathy is the leading cause of blindness in working-age adults. The condition progresses through stages, from mild nonproliferative retinopathy to advanced proliferative retinopathy where new, fragile blood vessels grow and can leak or bleed.

Regular eye exams can detect retinopathy early when treatment is most effective. Maintaining optimal eAG levels significantly reduces the risk of developing severe eye complications.

Metabolic and Hormonal Consequences

High estimated average glucose doesn't just affect blood sugar - it disrupts multiple metabolic and hormonal systems throughout the body, creating a cascade of health issues that extend far beyond diabetes.

Insulin Resistance and Metabolic Syndrome

Chronically elevated glucose leads to insulin resistance, where cells become less responsive to insulin's signals. This forces the pancreas to produce more insulin, creating a vicious cycle. Over time, this can progress to metabolic syndrome - a cluster of conditions including high blood pressure, abnormal cholesterol levels, excess abdominal fat, and elevated blood sugar.

Research in the journal Diabetes Care shows that individuals with an HbA1c above 5.7% have a significantly higher risk of developing metabolic syndrome within 5 years. This syndrome dramatically increases the risk of heart disease, stroke, and type 2 diabetes.

Hormonal Imbalances

High average glucose disrupts hormonal balance in multiple ways. In women, it can worsen polycystic ovary syndrome (PCOS) symptoms, interfere with fertility, and cause irregular menstrual cycles. In men, elevated glucose is associated with lower testosterone levels, reduced fertility, and erectile dysfunction.

The stress hormone cortisol also becomes dysregulated with chronic high blood sugar, potentially leading to further metabolic dysfunction, weight gain, and difficulty managing stress. These hormonal disruptions create a complex web of health issues that require comprehensive testing and management.

Cancer and Immune System Risks

Emerging research reveals concerning links between chronically elevated eAG and increased cancer risk. High glucose levels create an environment that promotes cancer cell growth and survival while simultaneously weakening the immune system's ability to detect and destroy abnormal cells.

A large meta-analysis published in Diabetologia found that individuals with diabetes have a 20-25% increased risk of developing cancer compared to those with normal glucose levels. The risk is particularly elevated for liver, pancreatic, endometrial, colorectal, breast, and bladder cancers. Even prediabetic eAG levels show increased cancer risk, suggesting that any elevation above optimal levels may be problematic.

High glucose also impairs immune function through multiple mechanisms. It reduces the effectiveness of white blood cells, increases inflammation, and disrupts the balance of immune responses. This not only increases infection risk but may also reduce the body's ability to identify and eliminate cancer cells early in their development.

Monitoring and Managing Your eAG Levels

Regular monitoring of your estimated average glucose through HbA1c testing is crucial for preventing the serious health risks associated with elevated levels. The frequency of testing depends on your current health status and risk factors.

Testing Recommendations

For individuals with normal eAG levels and no risk factors, annual testing may be sufficient. However, if you have prediabetes, a family history of diabetes, or other metabolic risk factors, testing every 3-6 months is recommended. Those actively working to improve their metabolic health should consider quarterly testing to track progress and adjust interventions as needed.

Beyond HbA1c, comprehensive metabolic testing including fasting glucose, insulin levels, and inflammatory markers provides a complete picture of your metabolic health. Continuous glucose monitoring (CGM) can also offer valuable insights into daily glucose patterns and help identify foods and activities that cause spikes.

Lifestyle Interventions

The good news is that high eAG levels can often be reversed through lifestyle changes. Dietary modifications focusing on whole foods, reducing refined carbohydrates, and increasing fiber intake can significantly improve glucose control. Regular physical activity, particularly resistance training and high-intensity interval training, enhances insulin sensitivity and glucose uptake by muscles.

Stress management through meditation, yoga, or other relaxation techniques helps regulate cortisol and improve glucose metabolism. Prioritizing sleep quality and duration is equally important, as poor sleep directly impacts glucose control. Weight loss, even modest amounts of 5-10% of body weight, can dramatically improve eAG levels in overweight individuals.

Taking Action to Protect Your Health

High estimated average glucose poses serious risks to virtually every system in your body, from immediate effects like fatigue and brain fog to long-term complications including heart disease, nerve damage, and cancer. The key to prevention lies in early detection and proactive management.

Don't wait for symptoms to appear - by the time you notice the effects of high eAG, significant damage may have already occurred. Regular testing allows you to catch elevations early when lifestyle interventions are most effective. Whether you're concerned about your current levels or want to optimize your metabolic health for longevity, understanding and monitoring your eAG is a crucial step.

Remember that optimal health isn't just about avoiding disease - it's about thriving with energy, mental clarity, and vitality. By maintaining healthy eAG levels through informed choices and regular monitoring, you're investing in both your immediate well-being and your long-term health potential.

References

  1. Nathan, D. M., Kuenen, J., Borg, R., Zheng, H., Schoenfeld, D., & Heine, R. J. (2008). Translating the A1C assay into estimated average glucose values. Diabetes Care, 31(8), 1473-1478.[Link][PubMed][DOI]
  2. Selvin, E., Steffes, M. W., Zhu, H., Matsushita, K., Wagenknecht, L., Pankow, J., ... & Brancati, F. L. (2010). Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. New England Journal of Medicine, 362(9), 800-811.[PubMed][DOI]
  3. Yaffe, K., Falvey, C. M., Hamilton, N., Harris, T. B., Simonsick, E. M., Strotmeyer, E. S., ... & Schwartz, A. V. (2013). Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Internal Medicine, 173(14), 1300-1306.[PubMed][DOI]
  4. Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., ... & Yee, D. (2010). Diabetes and cancer: a consensus report. Diabetes Care, 33(7), 1674-1685.[PubMed][DOI]
  5. Pop-Busui, R., Boulton, A. J., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., ... & Ziegler, D. (2017). Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care, 40(1), 136-154.[PubMed][DOI]
  6. Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., De Boer, I. H., Goldstein-Fuchs, J., ... & Molitch, M. E. (2014). Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care, 37(10), 2864-2883.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my estimated average glucose at home?

You can test your estimated average glucose at home with SiPhox Health's Core Health Program, which includes HbA1c testing. This CLIA-certified program provides lab-quality results from the comfort of your home, allowing you to monitor your average glucose levels every 3 months.

What is the difference between eAG and daily blood glucose readings?

Daily blood glucose readings show your blood sugar at a specific moment, while eAG represents your average blood sugar over the past 2-3 months. eAG is calculated from your HbA1c test and provides a more stable, long-term view of your glucose control, whereas daily readings can fluctuate based on meals, activity, and stress.

Can high eAG be reversed without medication?

Yes, many people can lower their eAG through lifestyle changes alone, especially when caught early. Dietary modifications, regular exercise, weight loss, stress management, and improved sleep can significantly reduce eAG levels. However, some individuals may require medication depending on how high their levels are and other health factors.

What eAG level should I aim for optimal health?

While an eAG below 117 mg/dL (HbA1c below 5.7%) is considered normal, many functional medicine practitioners recommend aiming for an eAG below 100 mg/dL (HbA1c below 5.0%) for optimal health and longevity. This lower target may help prevent the subtle metabolic damage that can occur even at 'normal' levels.

How quickly can eAG levels change with lifestyle interventions?

Since eAG reflects your average glucose over 2-3 months, it takes at least that long to see the full impact of lifestyle changes on your HbA1c test. However, you may notice improvements in daily glucose readings within days to weeks of making healthy changes, and these improvements will be reflected in your eAG over time.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details